Newborn Hyperbilirubinemia Assessment Calculator
This calculator applies the 2022 American Academy of Pediatrics (AAP) guidelines to assess whether a newborn's total serum bilirubin (TSB) level warrants phototherapy or escalated care. Enter the infant's age in hours, TSB result, gestational age, and any neurotoxicity risk factors. The tool returns the age- and risk-adjusted phototherapy threshold, the exchange transfusion threshold, and an interpretation of where the measured TSB sits relative to both thresholds.
What is neonatal hyperbilirubinemia?
Neonatal hyperbilirubinemia, commonly called newborn jaundice, occurs when bilirubin accumulates in the blood faster than the newborn liver can conjugate and excrete it. Bilirubin is a yellow pigment produced when red blood cells break down. In the first days of life, most newborns experience a physiological rise in bilirubin because fetal hemoglobin is being replaced and the immature liver has limited conjugating capacity. When the total serum bilirubin (TSB) rises beyond age-specific thresholds, it can cross the blood-brain barrier and deposit in the basal ganglia, a condition called acute bilirubin encephalopathy. If untreated, this can progress to kernicterus, a permanent and irreversible neurological injury. Early identification and timely phototherapy or, in severe cases, exchange transfusion, prevents this outcome.
How are phototherapy thresholds determined (2022 AAP guideline)?
The 2022 American Academy of Pediatrics Clinical Practice Guideline significantly revised phototherapy thresholds upward compared to the 2004 guidelines, reducing overtreatment while still preventing severe hyperbilirubinemia. Thresholds are now tailored to three variables: (1) the infant's postnatal age in hours, since bilirubin normally peaks between 72 and 120 hours in term infants; (2) gestational age at birth, because preterm infants have less blood-brain barrier protection; and (3) the presence of neurotoxicity risk factors including isoimmune hemolytic disease, G6PD deficiency, sepsis, asphyxia, significant lethargy, temperature instability, acidosis, or albumin below 3.0 g/dL. These three variables combine to assign infants to a Low, Medium, or High Risk tier, each with its own hour-specific TSB threshold curve. The exchange transfusion threshold sits approximately 5 mg/dL above the phototherapy threshold, and the escalation-of-care threshold is 2 mg/dL below the exchange threshold, signaling that transfer to a facility capable of exchange transfusion should be arranged before the critical level is reached.
Transcutaneous versus serum bilirubin
Transcutaneous bilirubin (TcB) measured by a bilirubinometer is a useful screening tool in the first 48 to 72 hours but is less reliable after phototherapy has begun (photo-bleaching of the skin artificially lowers the reading) and at higher bilirubin levels. A TcB above about 13-15 mg/dL should generally be confirmed with a venous total serum bilirubin before making treatment decisions. This calculator is designed for confirmed serum bilirubin values. Direct (conjugated) bilirubin is not included in the threshold comparison: if the direct fraction exceeds 1 mg/dL or is more than 20 percent of the total, a separate evaluation for cholestatic liver disease is warranted regardless of the total bilirubin level.
Bhutani nomogram and pre-discharge risk assessment
Before hospital discharge, the predischarge TSB or TcB can be plotted on the Bhutani hour-specific nomogram, which uses the 40th, 75th, and 95th percentile curves to stratify the infant into Low, Low-Intermediate, High-Intermediate, or High risk zones for subsequent significant hyperbilirubinemia. Infants in the High zone (above the 95th percentile) are at high risk of requiring phototherapy and need follow-up within 24 hours of discharge. This pre-discharge assessment complements the treatment thresholds calculated here, but uses a different framework: the nomogram is for predicting future risk, while the thresholds in this calculator determine whether treatment is needed now at the time of measurement.
Phototherapy thresholds by risk tier and age (mg/dL) - 2022 AAP
| Age (hours) | Low Risk | Medium Risk | High Risk |
|---|---|---|---|
| 12 | 9.5 | 8 | 6.5 |
| 24 | 12.5 | 10.5 | 9 |
| 48 | 15.5 | 13.5 | 11.5 |
| 72 | 17.5 | 15.5 | 13.5 |
| 96 | 18.5 | 16.5 | 14.5 |
| 120 | 19 | 17 | 15 |
| 168 | 19.5 | 17.5 | 15.5 |
Approximate phototherapy initiation thresholds derived from the 2022 AAP Clinical Practice Guideline. Exchange transfusion threshold is approximately 5 mg/dL above these values. Consult the full guideline figures for precise clinical use.
Frequently asked questions
What risk factors count as neurotoxicity risk factors under the 2022 AAP guideline?
The 2022 AAP guideline lists these neurotoxicity risk factors: isoimmune hemolytic disease (Rh, ABO, or other blood group incompatibility with a positive Coombs test), glucose-6-phosphate dehydrogenase (G6PD) deficiency, asphyxia or hypoxic-ischemic encephalopathy, significant lethargy or temperature instability, sepsis or clinical suspicion of sepsis, metabolic acidosis, and serum albumin below 3.0 g/dL. If any of these are present, the risk tier moves up (Low becomes Medium; Medium becomes High) and phototherapy is initiated at a lower TSB level.
Does gestational age alone change the threshold?
Yes. Even without additional risk factors, an infant born at 35 to 37 weeks and 6 days gestation is classified at Medium Risk, which means the phototherapy threshold is roughly 2-3 mg/dL lower than for a term infant with the same postnatal age. A 35 to 37-week infant who also has one or more risk factors is High Risk with thresholds lower still. Infants born at 38 weeks or more with no risk factors are Low Risk.
How often should bilirubin be checked near the phototherapy threshold?
The 2022 AAP guideline recommends that TSB be rechecked within 4 to 6 hours when it is within 2 mg/dL of the phototherapy threshold, within 12 to 24 hours when it is 2 to 3 mg/dL below the threshold, and within 24 to 48 hours for lower values in the follow-up period after discharge. The rate of rise matters: if bilirubin is climbing more than 0.5 mg/dL per hour, earlier rechecking is warranted.
When should phototherapy be stopped?
Phototherapy can be discontinued once the TSB has fallen at least 2 mg/dL below the phototherapy threshold and the infant is clinically well. After stopping phototherapy, TSB typically rebounds by 1 to 2 mg/dL over the next 24 hours, so a rebound check at 12 to 24 hours after discontinuation is recommended, particularly for infants who required phototherapy before 72 hours of age or who have hemolytic disease.
What is the difference between this calculator and the Bhutani nomogram?
The Bhutani nomogram (published 1999) stratifies a pre-discharge bilirubin into a risk zone (Low, Low-Intermediate, High-Intermediate, High) to predict which infants need close post-discharge follow-up. It does not directly tell you whether to start phototherapy. The 2022 AAP phototherapy thresholds used in this calculator tell you whether to treat now, based on the current measured TSB, the infant's exact age in hours, gestational age, and risk factors. The two tools serve different clinical purposes.
Can this calculator be used for infants under 35 weeks?
No. This calculator applies the 2022 AAP guideline, which covers infants of 35 completed weeks gestation or more. For more preterm infants, different (generally lower) thresholds apply, and management is governed by individual NICU protocols rather than a universal nomogram. For infants below 35 weeks, consult your institution's NICU guidelines or a neonatologist.
Is a bilirubin-to-albumin ratio used in treatment decisions?
Yes, for exchange transfusion decisions. The 2022 AAP guideline incorporates the bilirubin-to-albumin (B/A) ratio as a supplementary criterion for exchange transfusion: if the TSB-to-albumin ratio exceeds specified limits (roughly 8.0 mg/dL per g/dL for Low Risk, 7.2 for Medium Risk, 6.8 for High Risk), exchange transfusion may be indicated even when TSB alone has not yet crossed the exchange threshold. This calculator focuses on TSB-based thresholds; add a B/A ratio check for any infant approaching the exchange level.
Sources
- American Academy of Pediatrics, Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation (Pediatrics, 2022)
- Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns (Pediatrics, 1999)
- BiliTool - Online Neonatal Bilirubin Clinical Decision Support Tool (updated for AAP 2022 guidelines)